San Francisco, CA, United States of America

Dineli Wickramasinghe

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Dineli Wickramasinghe: Innovator in Antibody Constructs

Introduction

Dineli Wickramasinghe is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody constructs. With a total of nine patents to his name, Wickramasinghe's work is at the forefront of medical innovation.

Latest Patents

Wickramasinghe's latest patents include groundbreaking antibody constructs for CDH19 and CD3. These constructs comprise a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of a T cell. Additionally, he has developed nucleic acids encoding these antibody constructs, vectors comprising the nucleic acids, and host cells transformed or transfected with the vectors. His work also includes a process for the production of these antibody constructs, methods of using them, and a kit comprising the antibody constructs. Another notable patent involves a bispecific antibody construct that binds to both human CDH19 and CD3, along with the necessary nucleic acids and vectors for its production and medical use in treating melanoma.

Career Highlights

Wickramasinghe has worked with leading companies in the biotechnology sector, including Amgen Inc. and Amgen Research (Munich) GmbH. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in antibody technology.

Collaborations

Throughout his career, Wickramasinghe has collaborated with notable professionals in the field, including Shouhua Xiao and Zheng Pan. These collaborations have further enhanced his research and development efforts.

Conclusion

Dineli Wickramasinghe is a key figure in the development of innovative antibody constructs, with a strong patent portfolio that reflects his expertise and contributions to biotechnology. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…